TY - JOUR
T1 - Extracorporal life support for pulmonary hemorrhage in children
T2 - A case series
AU - Kolovos, Nikoleta S.
AU - Schuerer, Douglas J.E.
AU - Moler, Frank W.
AU - Bratton, Susan L.
AU - Swaniker, Fresca
AU - Bartlett, Robert H.
AU - Custer, Joseph R.
AU - Annich, Gail
PY - 2002
Y1 - 2002
N2 - Objective: To examine the use and outcome of extracorporeal life support in children with severe respiratory failure caused by pulmonary hemorrhage. Design: Retrospective case series report. Setting: Pediatric intensive care unit in a university children's hospital. Patients: Eight patients <19 yrs of age who required extracorporeal life support for severe respiratory failure associated with pulmonary hemorrhage. Interventions: Venoarterial or venovenous extracorporeal life support. Measurements: Ventilatory support parameters and systemic Pao2/Fio2 ratio before extracorporeal life support, time on extracorporeal life support, number of ventilator days, number of intensive care unit days, number of hospital days, continued bleeding on extracorporeal life support, and survival. Main Results: All patients had resolution of their pulmonary hemorrhage within 24 hrs. All patients survived to decannulation, extubation, and hospital discharge. All patients are alive, with follow-up times ranging from 1 to 10 yrs. Conclusions: Extracorporeal life support is not contraindicated in patients with severe respiratory failure with associated pulmonary hemorrhage and may be a life-sustaining supportive therapy.
AB - Objective: To examine the use and outcome of extracorporeal life support in children with severe respiratory failure caused by pulmonary hemorrhage. Design: Retrospective case series report. Setting: Pediatric intensive care unit in a university children's hospital. Patients: Eight patients <19 yrs of age who required extracorporeal life support for severe respiratory failure associated with pulmonary hemorrhage. Interventions: Venoarterial or venovenous extracorporeal life support. Measurements: Ventilatory support parameters and systemic Pao2/Fio2 ratio before extracorporeal life support, time on extracorporeal life support, number of ventilator days, number of intensive care unit days, number of hospital days, continued bleeding on extracorporeal life support, and survival. Main Results: All patients had resolution of their pulmonary hemorrhage within 24 hrs. All patients survived to decannulation, extubation, and hospital discharge. All patients are alive, with follow-up times ranging from 1 to 10 yrs. Conclusions: Extracorporeal life support is not contraindicated in patients with severe respiratory failure with associated pulmonary hemorrhage and may be a life-sustaining supportive therapy.
KW - Acute respiratory distress syndrome
KW - Autoimmune disease
KW - Extracorporeal life support
KW - Membrane oxygenation
KW - Pediatric
KW - Pulmonary hemorrhage
KW - Sepsis
KW - Vasculitis
UR - http://www.scopus.com/inward/record.url?scp=0036189509&partnerID=8YFLogxK
U2 - 10.1097/00003246-200203000-00014
DO - 10.1097/00003246-200203000-00014
M3 - Article
C2 - 11990918
AN - SCOPUS:0036189509
SN - 0090-3493
VL - 30
SP - 577
EP - 580
JO - Critical care medicine
JF - Critical care medicine
IS - 3
ER -